Dr. E. Prashanthi Reddy
MBBS, DGO, PG Diploma in ART — Kiel University, Germany | 19+ years as a Fertility Specialist | ART Act 2021 Certified | Lead Consultant, Mother Hospitals & IVF Center, Boduppal, Hyderabad
The endometrium — the inner lining of the uterus — must be sufficiently thick, well-vascularised, and receptive for an embryo to successfully implant. A thin endometrium (typically defined as less than 7 mm at the time of embryo transfer) is one of the more challenging causes of IVF failure and recurrent pregnancy loss. It affects approximately 2–8% of women undergoing IVF and is particularly common in patients with a history of uterine procedures.
This guide explains what a thin endometrium is, why it happens, and the range of treatments that Dr. Prashanthi Reddy at Mother Hospitals & IVF Center, Hyderabad uses to help patients overcome this obstacle.
What Is the Endometrium and Why Does Thickness Matter?
The endometrium is the mucous membrane lining the inside of the uterus. It thickens each month under the influence of estrogen during the first half of the menstrual cycle, then matures under progesterone in the second half to prepare for embryo implantation. If pregnancy does not occur, the endometrium sheds as a menstrual period.
During an IVF frozen embryo transfer (FET) cycle, the endometrium is prepared with estrogen supplements for 10–14 days. Ultrasound monitoring tracks its thickness and pattern. A "trilaminar" appearance (three distinct layers visible on ultrasound) combined with a thickness of 8–12 mm is ideal for embryo transfer.
When endometrial thickness falls below 7 mm — especially below 6 mm — implantation rates drop significantly. Research shows that the implantation rate per embryo drops from approximately 30% at 9 mm to under 10% at 6 mm.
What Causes a Thin Endometrium?
1. Asherman's Syndrome (Intrauterine Adhesions)
The most common cause of a persistently thin endometrium is Asherman's syndrome — scar tissue (adhesions) inside the uterine cavity that forms after trauma. Common triggers include D&C (dilation and curettage) for miscarriage management, post-partum haemorrhage, or uterine infection. Adhesions physically replace endometrial tissue, reducing the area available for thickening.
2. Poor Uterine Blood Flow
The endometrium depends on adequate blood supply from the uterine arteries. Poor perfusion — due to uterine artery anomalies, fibroids pressing on blood vessels, or systemic vascular conditions — results in inadequate estrogen delivery to the endometrium and failure to thicken.
3. Inadequate Estrogen Response
Even with normal estrogen supplementation, some women's endometria do not respond adequately. This may be due to reduced estrogen receptor expression or a history of long-term use of medications that affect endometrial growth.
4. Chronic Endometritis
Subclinical (silent) bacterial infection of the uterine lining — chronic endometritis — disrupts the endometrial environment and can contribute to both thin endometrium and implantation failure. It is diagnosed by hysteroscopy and endometrial biopsy and treated with targeted antibiotics.
Speak with Our Fertility Team
Have questions about thin endometrium or IVF? Dr. Prashanthi Reddy's team at Mother Hospitals & IVF Center is here to help.
Treatment Options for Thin Endometrium
Extended Estrogen Preparation
The first step is optimising estrogen dosage and duration. Switching from oral estradiol to transdermal patches or vaginal estradiol often improves endometrial response. Extending the preparation protocol from the standard 10–12 days to 21–28 days allows more time for the endometrium to thicken. Most thin endometrium cases respond to dose optimisation alone.
Sildenafil (Vaginal)
Sildenafil (commonly known as Viagra) applied vaginally acts as a vasodilator — it increases blood flow to the uterine arteries and improves endometrial perfusion. Multiple studies have shown that vaginal sildenafil (25–50 mg three times daily) can increase endometrial thickness by 1–2 mm in poor responders. It is generally well-tolerated and safe during the pre-transfer preparation phase.
G-CSF (Granulocyte Colony-Stimulating Factor) Infusion
G-CSF is a growth factor that stimulates stem cell recruitment to the endometrium, promoting growth and receptivity. It is administered as an intrauterine infusion during the endometrial preparation cycle. Research shows that G-CSF improves endometrial thickness and pregnancy rates in women with thin, refractory endometria — particularly those below 6 mm despite maximal estrogen therapy.
PRP (Platelet-Rich Plasma) Intrauterine Infusion
PRP contains concentrated growth factors from the patient's own blood that stimulate tissue regeneration. When infused into the uterine cavity, PRP has been shown in several studies to improve endometrial thickness and structure in women with Asherman's syndrome and poor endometrial response. It is a relatively new but promising intervention available at Mother Hospitals.
Pentoxifylline + Vitamin E
This combination therapy — pentoxifylline (a blood flow enhancer) and high-dose Vitamin E (an antioxidant) — has been used to treat thin endometrium caused by radiation or vascular damage. Some studies show modest improvement in endometrial thickness and blood flow after 3–6 months of treatment.
Hysteroscopy for Adhesion Treatment
When Asherman's syndrome is the cause, hysteroscopic adhesiolysis — the surgical removal of intrauterine scar tissue — is the primary treatment. After the procedure, estrogen is prescribed to stimulate endometrial regrowth over the treated area. Multiple hysteroscopic sessions may be needed for severe adhesions.
Success Rates with Thin Endometrium Treatment
| Intervention | Average Thickness Improvement | Success Rate |
|---|---|---|
| Extended Estrogen Protocol | 1–2 mm | Good (majority respond) |
| Vaginal Sildenafil | 1–2 mm | Moderate |
| G-CSF Infusion | 1.5–3 mm | Moderate–Good |
| PRP Infusion | 1–2.5 mm | Emerging evidence |
| Hysteroscopy (Asherman's) | Variable | Depends on severity |
Clinical note from Dr. Prashanthi Reddy: Thin endometrium is rarely a dead end. Most patients with persistently thin endometria can be successfully managed with a combination of the above treatments. The key is identifying the underlying cause through thorough investigation — not just escalating estrogen doses blindly.
When Is a Donor Embryo or Surrogate Considered?
In cases of severe Asherman's syndrome with near-complete destruction of the endometrial lining, it may not be possible to achieve a viable endometrium. In such cases, gestational surrogacy — where the embryo is carried by another woman with a healthy uterus — is a viable option. At Mother Hospitals, we discuss all options honestly so couples can make an informed decision.
Speak with Our Fertility Team
Have questions about your endometrium or IVF cycle? Dr. Prashanthi Reddy's team at Mother Hospitals & IVF Center is here to help.